Ушбу иш иқтибос қилган ишлар

177 та иш

Иш: Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects

1. DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes

   Yui Hatanaka, Takeshi Niinuma, Hiroshi Kitajima +15

   Мақола20212 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816542

2. Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN/STAT1 signaling pathway

   Yongcan Xu, Jun Lu, Neng Lou +4

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816545

3. Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA

   Ying Zhang, Meiying Luo, Xiaohong Cui +2

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816546

4. Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling

   Siyu Liu, Xiyi Chen, Ke Huang +9

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816551

5. circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment

   Roberta Piras, Emily Ko, Connor Barrett +13

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816552

6. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1–TINCR-USP20-PD-L1 axis

   Qin Wang, Guozheng Li, Xin Ma +10

   Мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816557

7. A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer

   Nan Ding, A‐Bin You, Hu Yang +4

   Мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816558

8. CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity

   Lulu Yu, Qi Xiao, Bing Yu +3

   Шарҳ мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816559

9. Exploring the regulatory role of lncRNA in cancer immunity

   Danting Zhan, Hong-chun Xian

   Шарҳ мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.816561

10. Gold nanoparticles attenuate the interferon-γ induced SOCS1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells

    Aisha Farhana, Abdullah Alsrhani, Naila Rasheed +1

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816562

11. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway

    Lin Du, Baojun Wang, Mengtong Wu +8

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816565

12. Engineered nanoparticles promote cardiac tropism of AAV vectors

    Lauren Switala, Lin Di, Huiyun Gao +5

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816570

13. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis

    Zimu Wang, Jing Luo, Hairong Huang +12

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816571

14. lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin

    Xiaoyan Yin, Haizhong Zhang, Jingmiao Wang +4

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816572

15. ADAR1-regulated miR-142-3p/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma

    Haoyuan Xu, Wanpeng Li, Kai Xue +9

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816573

16. Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response

    Kim Denise Fischer, Shashank Tiwari, Beatrice Thier +4

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816574

17. HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer

    Hayato Nishiyama, Takeshi Niinuma, Hiroshi Kitajima +9

    Мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816576

18. The AhR regulates IFN-induced immune checkpoints in lung cancer cells through HNRNPH1, an RNA-binding protein, and INCR1, a novel long non-coding RNA

    Brian Lara, Megan Snyder, Jocelyn Fimbres +5

    Мақола20252 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.816578

19. Tumor microenvironment complexity and therapeutic implications at a glance

    Roghayyeh Baghban, Leila Roshangar, Rana Jahanban‐Esfahlan +6

    Шарҳ мақола20202 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.827518

20. Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application

    Le Zhang, Xiaonan Xu, Xiulan Su

    Шарҳ мақола20202 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.839225

21. Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment

    Raffaele De Luca, Luca Gianotti, Paolo Pedrazzoli +13

    Шарҳ мақола20222 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.839251

22. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

    Matteo Santoni, Sebastiano Buti, Zin Myint +63

    Мақола20232 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.839256

23. CAR-engineered cell therapies: current understandings and future perspectives

    Mobina Bayat, Javid Sadri Nahand

    Мақола20262 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.839269

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.839187

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.839188